Technology
Health
Biotechnology

Unity Biotechnology

$7.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (1.07%) Today
-$0.34 (-4.48%) As of 4:02 PM EDT after-hours

Why Robinhood?

You can buy or sell UBX and other stocks, options, ETFs, and crypto commission-free!

About UBX

Unity Biotechnology, Inc. operates as a biotechnology company engaged in the research and development of therapeutics to extend the human health span. The company was founded by Nathaniel David, Jan van Deursen, Judith Campisi and Daohong Zhou in March 2009 and is headquartered in Brisbane, CA.

Employees
106
Headquarters
Brisbane, California
Founded
2009
Market Cap
322.09M
Price-Earnings Ratio
Dividend Yield
Average Volume
237.58K
High Today
$7.76
Low Today
$7.21
Open Price
$7.57
Volume
563.81K
52 Week High
$24.56
52 Week Low
$7.21

Collections

Technology
Health
Biotechnology
Research And Development
Therapy
2018 IPO
US
North America

UBX Earnings

-$4.69
-$3.27
-$1.85
-$0.43
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.